Skip to main content

Table 3 Clinical profile of diabetic patients and controls with and without PCO

From: Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus

Clinical Parameter

Diabetic subjects

Controls

P value (ANOVA)

 

PCO (n = 64)

Non-PCO (n = 41)

PCO (n = 22)

Non-PCO (n = 38)

 

Age (years), Mean ± SD

36.8 ± 4.28*

35.2 ± 4.4

34.2 ± 4.5

35.5 ± 4.6

0.000

Duration of DM (y), Mean ± SD

4.19 ± 2.0

2.9 ± 1.6 a

--

--

0.000

Age of menarche (y), Mean ± SD

13.5 ± 0.8

13.50 ± 0.6

13.1 ± 0.8

13.1 ± 0.7

0.015

Menstrual irregularity,

24 (37.5%)

4 (9.8%)

0

0

0.000

Oligomenorrhea

12 (18.8%)

1 (2.4%)

   

Polymenorrhea

1 (1.6%)

1 (2.4%)

   

Mennorrhagia

11 (17.2%)

2 (4.9%)

   

Infertility

4 (6.2%)

0

0

0

0.368

Hirsuitism

9 (14.1%)

0

4 (18.2%)

2 (5.3%)

0.030

Acne

3 (4.7%)

0

1 (4.5%)

1 (2.6%)

0.564

Acanthosis

2 (3.1%)

0

0

0

0.368

History of hypertension

40 (78%)

30 (73%)

0

0

0.000

SBP (mmHg), Mean ± SD

140 ± 12.7

139 ± 12.3

138 ± 9.5

130 ± 9.3 b

0.000

DBP (mmHg), Mean ± SD

85.8 ± 7.8

83.3 ± 7.3

82.1 ± 10.2

80.58 ± 7.5

0.012

BMI (kg/m2), Mean ± SD

25.8 ± 3.1

24.7 ± 3.3

26.36 ± 2.8

25.34 ± 3.3

0.180

Waist to hip ratio, Mean ± SD

0.94 ± 0.6

0.92 ± 0.7

0.94 ± 0.6

0.92 ± 0.6

0.426

Ovarian volume (ml), Mean ± SD

5.80 ± 1.18

4.13 ± 1.07

5.98 ± 1.28

3.89 ± 0.88

0.000

PCOS

39 (61%)

0

15 (68%)

0

0.000

  1. * on ultrasonography
  2. a: P < 0.05, in the subject group, b: P < 0.05, in control group
  3. PCOS by Rotterdam ASRM/ESHRE consensus criteria